Literature DB >> 27401710

A successful management of infection of the left ventricular assist device by pump exchange: conversion from DuraHeart to Jarvik 2000.

Shun Tanaka1, Kan Nawata2, Hiroto Kitahara1, Shuichi Yoshitake1, Takahiro Matsuoka1, Yoshifumi Itoda1, Osamu Kinoshita1, Mitsutoshi Kimura1, Minoru Ono1.   

Abstract

We successfully controlled infection of a left ventricular assist device by performing pump exchange. A 53-year-old man was implanted with DuraHeart for ischemic cardiomyopathy as a bridge to transplantation. Two years later, he was hospitalized with the diagnosis of driveline infection. The blood cultures detected Pseudomonas aeruginosa. During the admission, he developed brain hemorrhage perhaps due to septic emboli. The chest computed tomography scan revealed a small defect inside the outflow graft of the DuraHeart, which was highly suspected of vegetation. He underwent pump exchange, from DuraHeart to Jarvik 2000 with concomitant omentopexy. His postoperative course was uneventful, and he was discharged with no sequela of the brain hemorrhage. Four months after the pump exchange, he successfully underwent heart transplantation. No infectious tissue was observed in the pericardial space at the time of heart transplantation. Pump exchange is an effective way to manage refractory left ventricular assist device infection, and the timing of surgical intervention is of great importance.

Entities:  

Keywords:  DuraHeart; Infection; Jarvik 2000; Left ventricular assist device; Pump exchange

Mesh:

Year:  2016        PMID: 27401710     DOI: 10.1007/s10047-016-0919-4

Source DB:  PubMed          Journal:  J Artif Organs        ISSN: 1434-7229            Impact factor:   1.731


  6 in total

1.  Complex HeartMate II infection treated with pump exchange to HeartWare HVAD.

Authors:  Travis Abicht; Robert Gordon; Karen Meehan; Valentina Stosor; Patrick McCarthy; Edwin McGee
Journal:  ASAIO J       Date:  2013 Mar-Apr       Impact factor: 2.872

2.  Left ventricular assist device performance with long-term circulatory support: lessons from the REMATCH trial.

Authors:  Walter P Dembitsky; Alfred J Tector; Soon Park; Alan J Moskowitz; Annetine C Gelijns; Nuala S Ronan; William Piccione; William L Holman; Satoshi Furukawa; Alan D Weinberg; Gerald Heatley; Victor L Poirier; Laura Damme; James W Long
Journal:  Ann Thorac Surg       Date:  2004-12       Impact factor: 4.330

3.  Exchange techniques for implantable ventricular assist devices.

Authors:  Igor D Gregoric
Journal:  ASAIO J       Date:  2008 Jan-Feb       Impact factor: 2.872

4.  Device exchange after primary left ventricular assist device implantation: indications and outcomes.

Authors:  John M Stulak; Jennifer Cowger; Jonathon W Haft; Matthew A Romano; Keith D Aaronson; Francis D Pagani
Journal:  Ann Thorac Surg       Date:  2012-10-11       Impact factor: 4.330

5.  The Jarvik 2000 is associated with less infections than the HeartMate left ventricular assist device.

Authors:  M P Siegenthaler; J Martin; K Pernice; T Doenst; S Sorg; G Trummer; O Friesewinkel; F Beyersdorf
Journal:  Eur J Cardiothorac Surg       Date:  2003-05       Impact factor: 4.191

Review 6.  Dealing with surgical left ventricular assist device complications.

Authors:  Arman Kilic; Michael A Acker; Pavan Atluri
Journal:  J Thorac Dis       Date:  2015-12       Impact factor: 2.895

  6 in total
  2 in total

Review 1.  Journal of Artificial Organs 2016: the year in review : Journal of Artificial Organs Editorial Committee.

Authors:  Y Sawa; G Matsumiya; K Matsuda; E Tatsumi; T Abe; K Fukunaga; S Ichiba; A Kishida; K Kokubo; T Masuzawa; A Myoui; M Nishimura; T Nishimura; T Nishinaka; E Okamoto; S Tokunaga; T Tomo; T Tsukiya; Y Yagi; T Yamaoka
Journal:  J Artif Organs       Date:  2017-02-14       Impact factor: 1.731

2.  Readmissions after continuous flow left ventricular assist device implantation.

Authors:  Mitsutoshi Kimura; Kan Nawata; Osamu Kinoshita; Haruo Yamauchi; Yasuhiro Hoshino; Masaru Hatano; Eisuke Amiya; Koichi Kashiwa; Miyoko Endo; Yukie Kagami; Mariko Nemoto; Minoru Ono
Journal:  J Artif Organs       Date:  2017-07-27       Impact factor: 1.731

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.